{"id":"https://openalex.org/W7128407629","doi":"https://doi.org/10.6084/m9.figshare.31292398","title":"Impact of national volume-based procurement on physicians\u2019 antimicrobial prescribing behaviours: an interrupted time series analysis of 1200 prescriptions in a tertiary hospital","display_name":"Impact of national volume-based procurement on physicians\u2019 antimicrobial prescribing behaviours: an interrupted time series analysis of 1200 prescriptions in a tertiary hospital","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7128407629","doi":"https://doi.org/10.6084/m9.figshare.31292398"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.31292398","doi":"https://doi.org/10.6084/m9.figshare.31292398","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31292398","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.31292398","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5125429013","display_name":"Zhenzhen Du","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Du, Zhenzhen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125408597","display_name":"Jiapei Yao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yao, Jiapei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125399905","display_name":"Xinru Liu","orcid":"https://orcid.org/0009-0006-9047-1544","observed_orcids":["https://orcid.org/0009-0006-9047-1544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liu, Xinru","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125403168","display_name":"Jinhong Gong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gong, Jinhong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086261445","display_name":"Di Yang","orcid":"https://orcid.org/0000-0002-5749-9004","observed_orcids":["https://orcid.org/0000-0002-5749-9004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang, Di","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125407755","display_name":"Xin Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li, Xin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125429110","display_name":"Dan Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Su, Dan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125417219","display_name":"Xindie Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhou, Xindie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5159868226","display_name":"Jingjing Shang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shang, Jingjing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-prescribing","display_name":"antimicrobial prescribing","score":0.9869999885559082},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.7710000276565552},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.7379999756813049},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.640999972820282},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.6019999980926514},{"id":"https://openalex.org/keywords/fluoroquinolones","display_name":"fluoroquinolones","score":0.9179999828338623},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/physician-prescribing-behaviour","display_name":"physician prescribing behaviour","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.8330000042915344},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.8105999827384949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.774399995803833},{"id":"https://openalex.org/C2780089965","wikidata":"https://www.wikidata.org/wiki/Q39046682","display_name":"Interrupted time series","level":3,"score":0.7554000020027161},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.5825999975204468},{"id":"https://openalex.org/C201650216","wikidata":"https://www.wikidata.org/wiki/Q829492","display_name":"Procurement","level":2,"score":0.579800009727478},{"id":"https://openalex.org/C2909024267","wikidata":"https://www.wikidata.org/wiki/Q39046682","display_name":"Interrupted Time Series Analysis","level":2,"score":0.5231000185012817},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.48069998621940613},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4675000011920929},{"id":"https://openalex.org/C127142870","wikidata":"https://www.wikidata.org/wiki/Q7838279","display_name":"Trend analysis","level":2,"score":0.3671000003814697},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3384999930858612},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.33079999685287476},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.30709999799728394},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.29910001158714294},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.27219998836517334},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C2983335822","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost analysis","level":2,"score":0.2655999958515167},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2565999925136566},{"id":"https://openalex.org/C2780958618","wikidata":"https://www.wikidata.org/wiki/Q945621","display_name":"Average cost","level":2,"score":0.2531000077724457},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.25279998779296875}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.31292398","doi":"https://doi.org/10.6084/m9.figshare.31292398","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31292398","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.31292398.v1","doi":"https://doi.org/10.6084/m9.figshare.31292398.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31292398.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.31292398","doi":"https://doi.org/10.6084/m9.figshare.31292398","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.31292398","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7118471653","https://openalex.org/W4407830519","https://openalex.org/W4391648423","https://openalex.org/W4386613280","https://openalex.org/W4362523680","https://openalex.org/W4415146847","https://openalex.org/W7166809020","https://openalex.org/W4281696197","https://openalex.org/W4414703129","https://openalex.org/W4386441207"],"abstract_inverted_index":{"This":[0,31,187],"study":[1,32,55,188],"aimed":[2],"to":[3,277,330],"investigate":[4],"the":[5,8,54,57,65,139,185,192,202,214,221],"impact":[6],"of":[7,64,96,111,141,168,204,216,232,259,311],"National":[9,235,286],"Volume-Based":[10,236,287],"Procurement":[11,237,288],"(NVBP)":[12],"policy":[13,67,128,194,238,253,289,305],"on":[14,68],"antimicrobial":[15,82,145,170,209,227,241,266,274,292,318,327],"use":[16,203,258,310],"intensity,":[17],"prescribing":[18,83],"structure,":[19],"and":[20,45,60,77,200,207,229,244,281,295,334],"medical":[21],"costs":[22,247,298],"among":[23],"inpatients":[24],"in":[25,29,138,248,299],"a":[26,39,115,134,156,173,249,300],"tertiary":[27,40,251,302],"hospital":[28,41],"China.":[30],"retrospectively":[33],"extracted":[34],"1200":[35],"inpatient":[36],"prescriptions":[37],"from":[38],"between":[42],"April":[43],"2019":[44],"March":[46],"2024.":[47],"Using":[48],"interrupted":[49],"time":[50],"series":[51],"(ITS)":[52],"analysis,":[53],"assessed":[56],"immediate-level":[58],"changes":[59],"long-term":[61],"trend":[62,159,176],"effects":[63],"NVBP":[66,80,144,169,193,205],"medication":[69],"indicators":[70,124],"such":[71],"as":[72],"defined":[73],"daily":[74],"doses":[75],"(DDDs)":[76],"costs.":[78],"Following":[79],"implementation,":[81],"structure":[84],"changed":[85],"significantly,":[86],"with":[87,256,273,308,326],"\u03b2-lactam":[88],"utilization":[89],"decreasing":[90],"by":[91,102,155],"13.85%.":[92],"The":[93,234,285,304],"combination":[94,106],"rate":[95],"\u03b2-lactams":[97],"+":[98],"fluoroquinolones":[99],"fell":[100],"significantly":[101,126,195,239,290],"75.93%,":[103],"while":[104,191],"overall":[105],"therapy":[107],"remained":[108],"unchanged.":[109],"Use":[110],"special-grade":[112,217,260,312],"antimicrobials":[113,218],"showed":[114,172],"numerical":[116],"increase":[117],"(+31.98%),":[118],"although":[119],"not":[120],"statistically":[121],"significant.":[122],"Cost":[123],"decreased":[125],"following":[127],"implementation.":[129],"ITS":[130],"analysis":[131],"further":[132],"revealed":[133],"significant":[135,174],"immediate":[136],"decrease":[137],"proportion":[140,215],"DDDs":[142,167],"for":[143,223,265,317],"agents":[146,171],"(\u03b22":[147],"=":[148,152,161,178,182],"\u221215.464":[149],"units,":[150],"p":[151,163,181],"0.009),":[153],"followed":[154],"sustained":[157],"upward":[158,175],"(\u03b23":[160,177],"1.400/month,":[162],"<":[164],"0.001).":[165],"Similarly,":[166],"0.135":[179],"units/month,":[180],"0.017)":[183],"after":[184],"policy.":[186],"demonstrates":[189],"that":[190],"reduced":[196,240,291],"patient":[197,245,296],"drug":[198,242,268,293,321],"expenditures":[199,243,294],"promoted":[201],"varieties":[206],"nonrestricted":[208],"agents,":[210,219],"it":[211],"also":[212],"increased":[213,257,309],"suggesting":[220],"need":[222],"caution":[224],"against":[225],"potential":[226,263,315],"resistance":[228],"strengthened":[230],"supervision":[231],"prescription.":[233],"out-of-pocket":[246,297],"Chinese":[250,301],"hospital.The":[252],"was":[254,306],"associated":[255,307],"antimicrobials,":[261,313],"highlighting":[262,314],"risks":[264,316],"resistance.Future":[267],"procurement":[269,322],"policies":[270,323],"should":[271,324],"integrate":[272,325],"stewardship":[275,328],"programs":[276,329],"balance":[278,331],"cost":[279,332],"control":[280,333],"rational":[282,335],"antibiotic":[283,336],"use.":[284,337],"hospital.":[303],"resistance.":[319],"Future":[320]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-02-10T00:00:00"}